Inyx (IYXI) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


What is Inyx Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Inyx's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

IYXI vs NUVPF, ADMD, RSPI: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Inyx's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inyx Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inyx's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Inyx's Margin of Safety % (DCF Earnings Based) falls into.


Inyx Business Description

Address 825 3rd Avenue, 40th Floor, New York, NY, USA, 10022
Inyx Inc is focused on the development, manufacture, and marketing of prescription and over-the-counter aerosol products and drug delivery technologies for the treatment of respiratory, allergy, cardiovascular and dermatological, and topical conditions.